Prelude Capital Management’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

Prelude Capital Management’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-36,971	Closed	-$2.3M	–	1582
2023 Q4	$2.3M	Buy	+36,971	New	+$919K	0.15%	153

Prelude Capital Management's RYZB Position: Q1 2024 in Review

Prelude Capital Management sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 36,971 shares — an estimated $2.3M sold.

Prelude Capital Management first reported a position in RYZB in Q4 2023 and held it in 1 quarter. The position peaked at $2.3M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

Prelude Capital Management reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Prelude Capital Management sold 36,971 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $2.3M.
Prelude Capital Management first reported a position in RayzeBio, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Prelude Capital Management's RayzeBio, Inc. Common Stock position peaked at $2.3M in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on Prelude Capital Management's 13F filing for Q1 2024, filed 15 May 2024.